Cameroon vs France: Access to anti-retroviral drugs, female
Cameroon
95.0%
in 2024
France
93.0%
in 2022
Cameroon rank
19th
France rank
22nd
Access to anti-retroviral drugs, female over time
- Cameroon
- France
How they compare
Cameroon currently reports 95.0% against 93.0% in France, a difference of 2.0%.
Across all 23 years both countries report, France has been ahead every year.
Cameroon ranks 19th and France ranks 22nd of 141 countries.
France has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | France | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.2% | 81.2% | 77.0% | France |
| 2010s | 38.0% | 90.4% | 52.4% | France |
| 2020s | 81.7% | 91.7% | 10.0% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Cameroon or France?
- Cameroon, at 95.0% against 93.0% in France as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Cameroon and France?
- 2.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and France?
- 23 years are reported by both, from 2000 to 2022.
- How do Cameroon and France rank globally for access to anti-retroviral drugs, female?
- Cameroon ranks 19th and France ranks 22nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.